D.E. Shaw & Co’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-1,667
| Closed | -$504K | – | 4537 |
|
2021
Q4 | $504K | Buy |
+1,667
| New | +$504K | ﹤0.01% | 3084 |
|
2021
Q3 | – | Sell |
-968
| Closed | -$296K | – | 3900 |
|
2021
Q2 | $296K | Buy |
968
+729
| +305% | +$223K | ﹤0.01% | 3108 |
|
2021
Q1 | $49K | Buy |
+239
| New | +$49K | ﹤0.01% | 2904 |
|
2020
Q3 | – | Sell |
-191
| Closed | -$47K | – | 2834 |
|
2020
Q2 | $47K | Sell |
191
-40
| -17% | -$9.84K | ﹤0.01% | 2569 |
|
2020
Q1 | $42K | Sell |
231
-148
| -39% | -$26.9K | ﹤0.01% | 2600 |
|
2019
Q4 | $110K | Sell |
379
-718
| -65% | -$208K | ﹤0.01% | 2563 |
|
2019
Q3 | $299K | Buy |
1,097
+15
| +1% | +$4.09K | ﹤0.01% | 2277 |
|
2019
Q2 | $407K | Buy |
1,082
+165
| +18% | +$62.1K | ﹤0.01% | 2197 |
|
2019
Q1 | $246K | Buy |
917
+293
| +47% | +$78.6K | ﹤0.01% | 2324 |
|
2018
Q4 | $133K | Buy |
624
+323
| +107% | +$68.8K | ﹤0.01% | 2435 |
|
2018
Q3 | $135K | Buy |
+301
| New | +$135K | ﹤0.01% | 2416 |
|